Pharmaceutical Supplies Procurement for Indian Army Healthcare Needs

Work Description - NA

This tender, originating from the Department of Military Affairs under the Ministry of Defence, issued by the Indian Army, and bearing Bid Number GEM/2026/B/7651934, represents a significant procurement opportunity. With a bid start date of August 18, 2026, at 7:00 PM, and a closing date of August 20, 2026, at 1:00 PM, the Department is seeking to acquire a comprehensive range of pharmaceutical supplies. The tender encompasses a diverse list of medications, including Adenosine 3 mg/ml (2 ml Inj), Amphotericin-B 50 mg Inj, Darbepoietin alpha (25 mcg and 60 mcg Inj), Isoxsuprine 10mg Tab, L-Ornithine L Aspartate Powder (5gm), combination therapies such as Lamivudine 150mg/Stavudine 30mg/Nevirapine 200mg Tab and Zidovudine 300 mg/Lamivudine 150 mg/Nevirapine 200mg Tab, Letrozole 2.5 mg Tab, Levonorgestrel 0.25mg/Ethinylestradiol 0.03mg (pack of 21 tabs), LEVODOPA 200MG/CARBIDOPA 50 MG CR TAB, Lignocaine 2.5%/Prilocaine 2.5% (Tube 30 Gm), Paraffin Liquid (bottle of 100ml), Tab Lithium Carbonate 300mg, Lopinavir 200mg/Ritonavir 50mg Tab, Lorazepam 2mg/ml (2 ml Inj), Mesalamine 1 gm Sachet, Methimazole 5 mg tab, METHOTREXATE (15 MG TAB, 2.5mg Tab, and 5 mg Tab), Methylcobalamine 1500mcg/Alphalipoic acid 100mg (Nuhenz Cap), Metoclopramide 10 mg tab, Tab Metoprolol Extended Release 25mg, Metoprolol XL 12.5 mg Tab, Tab Mexiletine 150 mg, and Midodrine 2.5mg Tab. The total quantity required for this extensive list is 438,750 units, making this a substantial and critical procurement for the operational readiness and healthcare needs of the Indian Army. Interested and qualified suppliers are encouraged to review the full tender document for detailed specifications and submission requirements.